Lidocaine And Neuromonitoring in Thyroid Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

October 15, 2023

Study Completion Date

December 31, 2023

Conditions
Thyroid NeoplasmParathyroid NeoplasmsAnesthesia
Interventions
DRUG

Intravenous lidocaine

Lidocaine IV 1.5 mg / kg BMI will be administered during induction into anaesthesia followed by infusion at a dose of 1.5 mg / kg / h until the end of the surgery.

DRUG

Intravenous placebo

During induction and maintenance of anaesthesia, 0.9% sodium chloride solution will be injected intravenously at a rate equivalent to lidocaine solution.

PROCEDURE

Intra-cuff lidocaine

The lidocaine solution will be applied to the intubation tube and the cuff will be filled with an alkalinised lidocaine solution.

PROCEDURE

Intra-cuff placebo

The intubation tube will be lubricated 0.9% sodium chloride, the tube cuff will be filled with 0.9% sodium chloride solution.

Trial Locations (1)

Unknown

St. Petersburg State University Hospital, Saint Petersburg

All Listed Sponsors
lead

Saint Petersburg State University, Russia

OTHER

NCT04574947 - Lidocaine And Neuromonitoring in Thyroid Surgery | Biotech Hunter | Biotech Hunter